Evidence map›Paper›PMID 40483290›Full record

ArticleCommunications biology2025

Multilayer Integration of Networks Toolbox (MINT).

Saman Sarraf, Bárbara Avelar-Pereira, S M Hadi Hosseini, Alzheimer’s Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saman Sarraf *Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA, USA. ssarraf@stanford.edu.ORCID http://orcid.org/0000-0003-3314-4281
Bárbara Avelar-Pereira *Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4719-8504
S M Hadi HosseiniDepartment of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-5186-7008
Alzheimer’s Disease Neuroimaging Initiative

Funding

Microstructural changes in gray and white matter in aging and ADR01AG073362 · NIA · STANFORD UNIVERSITY · PI Hadi Hosseini · 2022 to 2026
$3.7M
Interactive Effects of Aging and AD on Brain NetworksR01AG072470 · NIA · STANFORD UNIVERSITY · PI Hadi Hosseini · 2022 to 2026
$2.9M
Development of a cost-effective and neurobiologically valid VR assessment tool for early detection of ADR21AG073973 · NIA · STANFORD UNIVERSITY · PI HOSSEINI, HADI · 2021 to 2022
$433k
Multi-dimensional network framework for AD detection and progressionR21AG064263 · NIA · STANFORD UNIVERSITY · PI HOSSEINI, HADI · 2019 to 2020
$430k
NIA NIH HHS R01 AG072470NIA NIH HHS R01 AG073362NIA NIH HHS R21 AG064263NIA NIH HHS R21 AG073973
6 · The paper itself

Abstract

We present MINT (Multilayer Integration of Networks Toolbox), a Python package for multimodal data integration and community detection. MINT includes data standardization, Similarity Network Fusion, Generalized Louvain clustering, visualization, cross-validation, and modality selection optimization, capturing complex relationships among disease markers. We applied MINT to two multimodal datasets spanning the Alzheimer's disease (AD) spectrum: a primary cohort of 206 participants and a validation cohort of 143 participants, including structural magnetic resonance imaging (MRI), amyloid positron emission tomography (PET), cerebrospinal fluid (CSF), cognition, and genetics. We hypothesized that modeling intra- and inter-modality associations would improve AD prediction and identify preclinical cases. Across both datasets, MINT identified PET and CSF as optimal modalities and detected two communities: one AD-dominant and one cognitively normal-dominant (CN). Sensitivity and specificity for CN and AD were 84.38% (95% CI: 73.14-92.24) and 92.65% (95% CI: 83.67-97.57). The AD-dominant community exhibited poorer cognition and higher genetic risk and AD pathology (p < 0.001). CN individuals in this group showed elevated amyloid (p=0.009), tau (p=0.004), and ptau (p < 0.001) compared to AD individuals in the CN-dominant group. MINT can identify biologically relevant subgroups, predict disease progression, and serves as a powerful tool for uncovering complex relationships across heterogeneous and multifactorial disorders.

Indexed as

Alzheimer DiseaseSoftwareAgedAged, 80 and overBiomarkersCognitionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyBiomarkers

Identifiers

PMID40483290
PMCPMC12145431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.